Can we ensure a safe and effective integration of language models in oncology?

• Chiara Corti,
• Leo A. Celi

Affiliations

Chiara Corti

Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy

Leo A. Celi

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA; Laboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Corresponding author. Harvard – MIT, Division of Health Science and Technology, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, 77 Massachusetts Ave, MIT E25-505, Cambridge, MA, 02139, United States.